Primary objective
- To assess the evidence on the accuracy of CGMS in detecting abnormalities of glycaemic control in children and adults with CF.
- To investigate the potential causes of heterogeneity [including age, severity of lung disease, glycaemic control, symptomatic and asymptomatic individuals, timing of testing (during stable disease or an infective exacerbation) and the type of CGMS] and their influence on the diagnostic accuracy of CGMS in CFRD.
- To identify gaps in the evidence and identify areas where further research is required.
This is a protocol.